Isoquinoline compounds and their use in treating AhR imbalance
The present invention is directed to novel compounds of Formula (I), or a pharmaceutically acceptable salt, solvate or hydrate thereof. Pharmaceutical compositions comprising a compound of Formula (I), or a pharmaceutically acceptable salt, solvate or hydrate thereof, are also described. The inventi...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
28.11.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to novel compounds of Formula (I), or a pharmaceutically acceptable salt, solvate or hydrate thereof. Pharmaceutical compositions comprising a compound of Formula (I), or a pharmaceutically acceptable salt, solvate or hydrate thereof, are also described. The invention is also directed to use of the compounds of Formula (I) for treating a condition in a mammal associated with AhR imbalance, such as an inflammatory disease or disorder. |
---|---|
Bibliography: | Application Number: US202218050888 |